Page 27 - Prezentacja programu PowerPoint

EM-MED is a family owned company group which has been on the
medical market for more than 30 years. In the early years EM-
MED’s main function was the distribution of disposables. Later
medical devices were added to the product portfolio and now EM-
MED primarily distributes devices in the fields of non-invasive
hemodynamic monitoring, neonatology and temperature
management. Being the local market leader in many product
categories a decision was made to move into the production of
medical devices where our goal is to develop highest quality
products. Our latest development is the TrueCool therapeutic
hypothermia device which is possibly the most advanced device of
its kind on the market.

TrueCool is a therapeutic hypothermia device which is used to John Zandbergen
deliberately reduce the core body temperature in patients who do
not regain consciousness after return of spontaneous circulation Export manager EMEA
following a cardiac arrest, as well as in newborns with hypoxic- john@em-med.com
ischemic encephalopathy. This is done to reduce neurological +31 26 848 7183
damages by decreasing the brain's oxygen demand and to reduce
the production of neurotransmitters like glutamate, as well as
reducing free radicals that might damage the brain. Therapeutic
hypothermia may be one of the most important recent clinical
advancements in the science of resuscitation.

Key features of our device: probably the most accurate
device on the market)
• Non-invasive surface
cooling • Pathogen decontamination
module (so far we are the Patrick Oh Han Khong
• Multiple automatic and only ones that are able to Export manager APAC
manual cooling and directly address infection
warming programs patrick@em-med.com
concerns)
• Efficient cooling (most • and many more features +65 90171822
probably the fastest that distinguish us from the
cooling times)
competition
• High accuracy (most
Website Catalog

The market: The global
therapeutic hypothermia
systems market is expected
to reach USD 2.78 billion by
2023 from USD 2.46 billion
in 2018, growing at a CAGR
of 2.5%. If you are a medical
device distributor with
experience in the ICU, ER or
OR get in touch with us to
discuss distribution
opportunities.

27 Polish Investment & Trade Agency